These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19277407)

  • 21. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
    Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
    Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
    Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy.
    Ittel A; Bretelle F; Gris JC; Chau C; Sébahoun G; Boubli L; Arnoux D
    Thromb Haemost; 2011 Jan; 105(1):66-71. PubMed ID: 20978710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.
    Hansen JB; Sandset PM; Huseby KR; Huseby NE; Nordøy A
    Thromb Haemost; 1996 Nov; 76(5):703-9. PubMed ID: 8950777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
    J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
    Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of tissue factor pathway inhibitor-1 on no-reflow in a rabbit model].
    Luo JG; Chen YD; Tian F; Wang CH; Lü Y; Yang XX; Lü SZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1113-8. PubMed ID: 20193184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue factor pathway inhibitor release and depletion by sulodexide in humans.
    Borawski J; Gozdzikiewicz J; Dubowski M; Pawlak K; Mysliwiec M
    Adv Med Sci; 2009; 54(1):32-6. PubMed ID: 19731406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A; Kotschy M; Jawien A
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort.
    Sakkinen PA; Cushman M; Psaty BM; Kuller LH; Bajaj SP; Sabharwal AK; Boineau R; Macy E; Tracy RP
    Thromb Haemost; 1998 Jul; 80(1):134-9. PubMed ID: 9684799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
    Xu P; Qi XY; Li CH; Zhang JH; Liu DM; Liu J; Wang WL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine unbalances endothelial tissue factor and tissue factor pathway inhibitor expression.
    Steffel J; Iseli S; Arnet C; Lüscher TF; Tanner FC
    J Mol Cell Cardiol; 2006 May; 40(5):746-9. PubMed ID: 16516912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients].
    Kemona-Chetnik I; Bodzenta-Lukaszyk A; Kucharewicz I; Rogalewska AM
    Przegl Lek; 2005; 62(2):98-101. PubMed ID: 16095153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.